|
Market Closed -
Nasdaq
16:00:00 2026-11-13 EST
|
5-day change | 1st Jan Change | ||
| 4.830 USD | -0.41% |
|
+10.02% | +43.32% |
| 11-12 | Novo Holdings-backed Windward Bio raises $175 million in US IPO | RE |
| 11-06 | Ironwood Pharmaceuticals, Inc., Q3 2026 Earnings Call, Nov 05, 2026 |
| Market Cap | 800M 725M 670M 605M 1.14B 75.39B 1.18B 8.05B 3.19B 40.27B 3B 2.94B 128B | P/E 2026 * |
3.71x | P/E 2027 * | 3.55x |
|---|---|---|---|---|---|
| Enterprise Value | 800M 725M 670M 605M 1.14B 75.39B 1.18B 8.05B 3.19B 40.27B 3B 2.94B 128B | EV / Sales 2026 * |
1.62x | EV / Sales 2027 * | 1.59x |
| Free-Float |
96.77% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IRWD | Delayed | |
| IRWD | Real-time | ||
| I76 | Real-time | ||
| I76 | Delayed | ||
| I76 | Delayed | ||
| I76 | Real-time |
Last Transcript: Ironwood Pharmaceuticals, Inc.
| 1 day | -0.41% | ||
| 1 week | +10.02% | ||
| Current month | +38.00% | ||
| 1 month | +34.54% | ||
| 3 months | +18.38% | ||
| 6 months | +31.25% | ||
| Current year | +43.32% |
| 1 week | 4.34 | 5 | |
| 1 month | 3.38 | 5 | |
| Current year | 2.95 | 5.78 | |
| 1 year | 2.95 | 5.78 | |
| 3 years | 0.53 | 15.7 | |
| 5 years | 0.53 | 15.7 | |
| 10 years | 0.53 | 21.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas McCourt
CEO | Chief Executive Officer | 68 | 2021-03-11 |
Ronald Silver
DFI | Director of Finance/CFO | 44 | 2026-05-14 |
Jeffrey Silber
CTO | Chief Tech/Sci/R&D Officer | - | 2026-07-19 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas McCourt
BRD | Director/Board Member | 68 | 2021-06-03 |
Julie McHugh
CHM | Chairman | 61 | 2019-03-31 |
Marla Kessler
BRD | Director/Board Member | 56 | 2019-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/15/26 | Free | Director | 3,694 | 0.0022% | ||
| 7/20/26 | Free | Chief Technology Officer | 137,036 | 0.0832% | ||
| 7/7/26 | Sell | Chief Financial Officer | -127,890 | 0.0777% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.41% | +10.02% | +43.32% | -48.56% | 800M | ||
| +1.26% | +6.61% | +41.12% | +135.59% | 1,286B | ||
| +0.79% | +3.45% | +46.35% | +93.56% | 688B | ||
| +0.20% | +1.28% | +27.01% | +112.80% | 521B | ||
| -0.44% | +3.69% | +39.60% | +69.51% | 386B | ||
| +0.55% | +0.70% | +59.00% | +44.20% | 364B | ||
| -0.12% | +0.74% | +26.78% | +58.43% | 302B | ||
| +0.37% | +0.37% | +3.62% | +36.44% | 287B | ||
| -0.30% | +1.14% | +38.59% | +74.61% | 252B | ||
| +0.08% | +0.71% | +34.25% | +124.32% | 208B | ||
| Average | +0.20% | +3.90% | +35.96% | +70.09% | 430B | |
| Weighted average by Cap. | +0.54% | +3.26% | +37.63% | +96.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 494M 447M 414M 373M 704M 46.54B 728M 4.97B 1.97B 24.86B 1.85B 1.81B 78.92B | 504M 457M 423M 381M 719M 47.54B 744M 5.08B 2.01B 25.4B 1.89B 1.85B 80.61B |
| Net income | 217M 197M 182M 164M 309M 20.47B 320M 2.19B 867M 10.93B 815M 797M 34.7B | 236M 214M 198M 179M 337M 22.27B 349M 2.38B 943M 11.9B 887M 868M 37.77B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-13 | US$4.830 | -0.41% | 2,808,074 |
| 26-11-12 | US$4.850 | -0.41% | 3,568,998 |
| 26-11-11 | US$4.870 | +1.25% | 2,821,048 |
| 26-11-10 | US$4.810 | +2.78% | 4,594,417 |
| 26-11-09 | US$4.680 | +6.61% | 5,331,411 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- IRWD Stock
Select your edition
All financial news and data tailored to specific country editions
















